Publication Cover
Canadian Journal of Pain
Revue canadienne de la douleur
Volume 7, 2023 - Issue 1
1,613
Views
1
CrossRef citations to date
0
Altmetric
Review

Healthcare provider knowledge, beliefs, and attitudes regarding opioids for chronic non-cancer pain in North America prior to the emergence of COVID-19: A systematic review of qualitative research

, , , ORCID Icon & ORCID Icon
Article: 2156331 | Received 30 May 2022, Accepted 05 Dec 2022, Published online: 17 Feb 2023

References

  • Volkow ND, McLellan AT. Opioid abuse in chronic pain–misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253–28. doi:10.1056/NEJMra1507771.
  • Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287–333. doi:10.1016/j.ejpain.2005.06.009.
  • Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16(8):769–80. doi:10.1016/j.jpain.2015.05.002.
  • Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol. 2008;16(5):405–16. doi:10.1037/a0013628.
  • Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–74. doi:10.1146/annurev-publhealth-031914-122957.
  • Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487.
  • Drug Abuse Warning Network. Substance abuse treatment admissions by primary substance of abuse, according to sex, age group, race, and ethnicity: the DAWN report. 2013;800–729 https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.htm.
  • Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
  • Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS data brief 2014. 2014;(166):1–8.
  • Busse JW, Wang L, Kamaleldin M, Craigie S, Riva JJ, Montoya L, Mulla SM, Lopes LC, Vogel N, Chen E, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320(23):2448–60. doi:10.1001/jama.2018.18472.
  • Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624–45. doi:10.1001/jama.2016.1464.
  • Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659–66. doi:10.1503/cmaj.170363.
  • Clarke H, Bao J, Weinrib A, Dubin RE, Kahan M. Canada’s hidden opioid crisis: the health care system’s inability to manage high-dose opioid patients: fallout from the 2017 Canadian opioid guidelines. Can Fam Physician. 2019;65:612–14.
  • Furlan AD, Williamson OD. New Canadian guidance on opioid use for chronic pain: necessary but not sufficient. CMAJ. 2017;189(18):E650–E1. doi:10.1503/cmaj.170431.
  • Lynch ME, Katz J. “One size fits all” doesn’t fit when it comes to long-term opioid use for people with chronic pain. Can J Pain. 2017;1(1):2–7. doi:10.1080/24740527.2017.1319733.
  • Gallagher R, Hatcher L. Will the new opioid guidelines harm more people than they help? Yes. Can Fam Physician. 2018;64:101–02.
  • Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA psychiatry. 2014;71(7):821–26. doi:10.1001/jamapsychiatry.2014.366.
  • Belzak L, Halverson J. The opioid crisis in Canada: a national perspective. Health Promot Chronic Dis Prev Can. 2018;38(6):224–33. doi:10.24095/hpcdp.38.6.02.
  • Federal, provincial, and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and stimulant-related harms in Canada. Ottawa (Ontario, Canada): Public Health Agency of Canada; 2022 Mar.
  • Toye F, Seers K, Tierney S, Barker KL. A qualitative evidence synthesis to explore healthcare professionals’ experience of prescribing opioids to adults with chronic non-malignant pain. BMC Fam Pract. 2017;18(1):94. doi:10.1186/s12875-017-0663-8.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–69. doi:10.7326/0003-4819-151-4-200908180-00135.
  • Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12:181. doi:10.1186/1471-2288-12-181.
  • Rash JA, Buckley N, Busse JW, Campbell TS, Corace K, Cooper L, Flusk D, Iorio A, Lavoie KL, Poulin PA, et al. Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review. Syst Rev. 2018;7(1): Article number 189. doi:10.1186/s13643-018-0858-7.
  • Fischer B, Keates A, Buhringer G, Reimer J, Rehm J. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction. 2014;109(2):177–81. doi:10.1111/add.12224.
  • Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan — a web and mobile app for systematic reviews. Systematic Reviews. 2016;5:210. doi:10.1186/s13643-016-0384-4.
  • Malterud K. Qualitative metasynthesis: a research method for medicine and health sciences. New York (NY): Routledge; 2019.
  • Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. doi:10.1186/1471-2288-8-45.
  • Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, Foy R, Duncan EM, Colquhoun H, Grimshaw JM, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77. doi:10.1186/s13012-017-0605-9.
  • Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37. doi:10.1186/1748-5908-7-37.
  • Critical Appraisal Skills Programme. CASP qualitative checklist; 2018 [ accessed 2018 Mar 25]. https://casp-uk.net/wp-content/uploads/2018/01/CASP-Qualitative-Checklist-2018.pdf.
  • Noyes J, Booth A, Flemming K, Garside R, Harden A, Lewin S, Pantoja T, Hannes K, Cargo M, Thomas J. Cochrane qualitative and implementation methods group guidance paper 3: methods for assessing methodological limitations, data extraction and synthesis, and confidence in synthesized qualitative findings. J Clin Epidemiol. 2018;97:49–58. doi:10.1016/j.jclinepi.2017.06.020.
  • Thomas J, Harden A, Oakley A, Oliver S, Sutcliffe K, Rees R, Brunton G, Kavanagh J. Integrating qualitative research with trials in systematic reviews. BMJ. 2004;328(7446):1010–12. doi:10.1136/bmj.328.7446.1010.
  • Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O’Connor PG, Schottenfeld RS, Fiellin DA. Opioids, chronic pain, and addiction in primary care. J Pain. 2010;11(12):1442–50. doi:10.1016/j.jpain.2010.04.002.
  • Buchman DZ, Ho A, Illes J. You present like a drug addict: patient and clinician perspectives on trust and trustworthiness in chronic pain management. Pain Med. 2016;17(8):1394–406. doi:10.1093/pm/pnv083.
  • Calcaterra SL, Drabkin AD, Leslie SE, Doyle R, Koester S, Frank JW, Reich JA, Binswanger IA. The hospitalist perspective on opioid prescribing: a qualitative analysis. J Hosp Med. 2016;11(8):536–42. doi:10.1002/jhm.2602.
  • Chang JS, Kushel M, Miaskowski C, Ceasar R, Zamora K, Hurstak E, Knight KR. Provider experiences with the identification, management, and treatment of co-occurring chronic noncancer pain and substance use in the safety net. Subst Use Misuse. 2017;52(2):251–55. doi:10.1080/10826084.2016.1223138.
  • Chang Y, Zhu KL, Florez ID, Cho SM, Zamir N, Toma A, Mirza RD, Guyatt GH, Buckley N, Busse JW. Attitudes toward the Canadian guideline for safe and effective use of opioids for chronic non-cancer pain: a qualitative study. J Opioid Manag. 2016;12(6):377–87. doi:10.5055/jom.2016.0357.
  • Clark LG, Upshur CC. Family medicine physicians’ views of how to improve chronic pain management. J Am Board Fam Med. 2007;20(5):479–82. doi:10.3122/jabfm.2007.05.070029.
  • Click IA, Basden JA, Bohannon JM, Anderson H, Tudiver F. Opioid prescribing in rural family practices: a qualitative study. Subst Use Misuse. 2018;53(4):533–40. doi:10.1080/10826084.2017.1342659.
  • Elder NC, Simmons T, Regan S, Gerrety E. Care for patients with chronic nonmalignant pain with and without chronic opioid prescriptions: a report from the Cincinnati area research group (CARinG) network. J Am Board Fam Med. 2012;25(5):652–60. doi:10.3122/jabfm.2012.05.120032.
  • Esquibel AY, Borkan J. Doctors and patients in pain: conflict and collaboration in opioid prescription in primary care. Pain. 2014;155(12):2575–82. doi:10.1016/j.pain.2014.09.018.
  • Fischer MA, McKinlay JB, Katz JN, Gerstenberger E, Trachtenberg F, Marceau LD, Welch LC. Physician assessments of drug seeking behavior: a mixed methods study. PLoS One. 2017;12(6):e0178690. doi:10.1371/journal.pone.0178690.
  • Fontana JS. The social and political forces affecting prescribing practices for chronic pain. J Prof Nurs. 2008;24(1):30–35. doi:10.1016/j.profnurs.2007.06.002.
  • Harle CA, Bauer SE, Hoang HQ, Cook RL, Hurley RW, Fillingim RB. Decision support for chronic pain care: how do primary care physicians decide when to prescribe opioids? A qualitative study. BMC Family Practice. 2015;16:48. doi:10.1186/s12875-015-0264-3.
  • Hurstak EE, Kushel M, Chang J, Ceasar R, Zamora K, Miaskowski C, Knight K. The risks of opioid treatment: perspectives of primary care practitioners and patients from safety-net clinics. Subst Abus. 2017;38(2):213–21. doi:10.1080/08897077.2017.1296524.
  • Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. “Those conversations in my experience don’t go well”: a qualitative study of primary care provider experiences tapering long-term opioid medications. Pain Med. 2017.
  • Knight KR, Kushel M, Chang JS, Zamora K, Ceasar R, Hurstak E, Miaskowski C. Opioid pharmacovigilance: a clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use. Soc Sci Med. 2017;186:87–95. doi:10.1016/j.socscimed.2017.05.043.
  • Liddy C, Smyth C, Poulin PA, Joschko J, Sheppard M, Keely E. Supporting better access to chronic pain specialists: the Champlain BASE TM eConsult service. J Am Board Fam Med. 2017;30(6):766–74. doi:10.3122/jabfm.2017.06.170170.
  • Penney LS, Ritenbaugh C, DeBar LL, Elder C, Deyo RA. Provider and patient perspectives on opioids and alternative treatments for managing chronic pain: a qualitative study. BMC Fam Pract. 2017;17(1): Article 164. doi:10.1186/s12875-016-0566-0.
  • Robertson A, Hitzig SL, Furlan AD. An evaluation of the performance of the opioid manager clinical tool in primary care: a qualitative study. J Opioid Manag. 2014;10(3):187–99. doi:10.5055/jom.2014.0207.
  • Spitz A, Moore AA, Papaleontiou M, Granieri E, Turner BJ, Reid MC. Primary care providers’ perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study. BMC Geriatrics. 2011;11:35. doi:10.1186/1471-2318-11-35.
  • Desveaux L, Saragosa M, Kithulegoda N, Ivers NM. Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study. BMC Fam Pract. 2019;20(1):59. doi:10.1186/s12875-019-0947-2.
  • Hulen E, Saha S, Morasco BJ, Zeigler C, Mackey K, Edwards ST. Sources of distress in primary care opioid management and the role of a controlled substance review group: a qualitative study. Pain Med. 2018;19(8):1570–77. doi:10.1093/pm/pnx259.
  • Kang I, Urick B, Vohra R, Ives TJ. Physician-pharmacist collaboration on chronic non-cancer pain management during the opioid crisis: a qualitative interview study. Res Social Adm Pharm. 2019;15(8):1027–31. doi:10.1016/j.sapharm.2019.04.052.
  • Militello LG, Anders S, Downs SM, Diiulio J, Danielson EC, Hurley RW, Harle CA. Understanding how primary care clinicians make sense of chronic pain. Cogn Technol Work. 2018;20(4):575–84. doi:10.1007/s10111-018-0491-1.
  • Satterwhite S, Knight KR, Miaskowski C, Chang JS, Ceasar R, Zamora K, Kushel M. Sources and impact of time pressure on opioid management in the safety-net. J Am Board Fam Med. 2019;32(3):375–82. doi:10.3122/jabfm.2019.03.180306.
  • Tong ST, Hochheimer CJ, Brooks EM, Sabo RT, Jiang V, Day T, Rozman JS, Kashiri PL, Krist AH. Chronic opioid prescribing in primary care: factors and perspectives. Ann Fam Med. 2019;17(3):200–06. doi:10.1370/afm.2357.
  • Wyse JJ, Ganzini L, Dobscha SK, Krebs EE, Morasco BJ. Setting expectations, following orders, safety, and standardization: clinicians’ strategies to guide difficult conversations about opioid prescribing. J Gen Intern Med. 2019;34(7):1200–06. doi:10.1007/s11606-019-04983-y.
  • Wyse JJ, Ganzini L, Dobscha SK, Krebs EE, Zamudio J, Morasco BJ. Clinical strategies for the treatment and management of patients prescribed long-term opioid therapy. Pain Medicine. 2018;20(9):1737–1744. doi:10.1093/pm/pny211.
  • Berger R. Now I see it, now I don’t: researcher’s position and reflexivity in qualitative research. Qual Res. 2015;15(2):219–34. doi:10.1177/1468794112468475.
  • Blumenthal-Barby JS, Krieger H. Cognitive biases and heuristics in medical decision making: a critical review using a systematic search strategy. Med decis making. 2015;35(4):539–57. doi:10.1177/0272989X14547740.
  • Saini V, Garcia-Armesto S, Klemperer D, Paris V, Elshaug AG, Brownlee S, Ioannidis JPA, Fisher ES. Drivers of poor medical care. Lancet. 2017;390(10090):178–90. doi:10.1016/S0140-6736(16)30947-3.
  • Cioffi J. A study of the use of past experiences in clinical decision making in emergency situations. Int J Nurs Stud. 2001;38(5):591–99. doi:10.1016/S0020-7489(00)00096-1.
  • Hall KH. Reviewing intuitive decision-making and uncertainty: the implications for medical education. Med Edu. 2002;36(3):216–24. doi:10.1046/j.1365-2923.2002.01140.x.
  • McCaffrey R, Zerwekh J, Keller K. Pain management: cognitive restructuring as a model for teaching nursing students. Nurse Educ. 2005;30(5):226–30. doi:10.1097/00006223-200509000-00012.
  • Graber ML, Trowbridge R, Myers JS, Umscheid CA, Strull W, Kanter MH. The next organizational challenge: finding and addressing diagnostic error. Jt Comm J Qual Patient Saf. 2014;40(3):102–10. doi:10.1016/s1553-7250(14)40013-8.
  • Ogdie AR, Reilly JB, Pang WG, Keddem S, Barg FK, Von Feldt JM, Myers JS. Seen through their eyes: residents’ reflections on the cognitive and contextual components of diagnostic errors in medicine. Acad med. 2012;87(10):1361–67. doi:10.1097/ACM.0b013e31826742c9.
  • Royce CS, Hayes MM, Schwartzstein RM. Teaching critical thinking: a case for instruction in cognitive biases to reduce diagnostic errors and improve patient safety. Acad med. 2019;94(2):187–94. doi:10.1097/ACM.0000000000002518.
  • Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med. 2015;162(4):276–86. doi:10.7326/M14-2559.
  • Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM. Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med. 2011;5(1):e13–22. doi:10.1016/j.jpain.2008.10.008.
  • Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. JAMA netw open. 2018;1(2):e180217. doi:10.1001/jamanetworkopen.2018.0217.
  • Juurlink DN, Dhalla IA. Dependence and addiction during chronic opioid therapy. J Med Toxicol. 2012;8(4):393–99. doi:10.1007/s13181-012-0269-4.
  • Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314(14):1468–78. doi:10.1001/jama.2015.11859.
  • Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: a review. JAMA psychiatry. 2019;76(2):208–16. doi:10.1001/jamapsychiatry.2018.3126.
  • Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975-2015: overview, key findings on adolescent drug use. Ann Arbor (MI, USA): Institute for Social Research, The University of Michigan; 2016.
  • Kennedy-Hendricks A, Gielen A, McDonald E, McGinty EE, Shields W, Barry CL. Medication sharing, storage, and disposal practices for opioid medications among US adults. JAMA Intern Med. 2016;176(7):1027–29. doi:10.1001/jamainternmed.2016.2543.
  • Hulme S, Bright D, Nielsen S. The source and diversion of pharmaceutical drugs for non-medical use: a systematic review and meta-analysis. Drug Alcohol Depend. 2018;186:242–56. doi:10.1016/j.drugalcdep.2018.02.010.
  • Canadian Agency for Drugs and Technologies in Health (CADTH). Opioid management practices for the prevention of drug diversion and misuse: a review of the clinical evidence and guidelines. Ottawa (Canada): CADTH. Rapid response review; 2012.
  • Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012;15(3 Suppl):ES191–203. doi:10.36076/ppj.2012/15/ES191.
  • Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305(13):1346–47. doi:10.1001/jama.2011.369.
  • Vranken MJ, Lisman JA, Mantel-Teeuwisse AK, Jünger S, Scholten W, Radbruch L, Payne S, Schutjens MH. Barriers to access to opioid medicines: a review of national legislation and regulations of 11 central and Eastern European countries. Lancet Oncol. 2016;17(1):e13–22. doi:10.1016/S1470-2045(15)00365-4.
  • Furlan AD, Carnide N, Irvin E, Van Eerd D, Munhall C, Kim J, Li CMF, Hamad A, Mahood Q, MacDonald S. A systematic review of strategies to improve appropriate use of opioids and to reduce opioid use disorder and deaths from prescription opioids. Can J Pain. 2018;2(1):218–35. doi:10.1080/24740527.2018.1479842.
  • Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77(4):219–26. doi:10.1159/000126073.
  • Matthias MS. Opioid tapering and the patient-provider relationship. J Gen Intern Med. 2020;35(1):8–9. doi:10.1007/s11606-019-05337-4.
  • Punwasi R, de Kleijn L, Rijkels-Otters JBM, Veen M, Chiarotto A, Koes B. General practitioners’ attitudes towards opioids for non-cancer pain: a qualitative systematic review. BMJ open. 2022;12(2):e054945. doi:10.1136/bmjopen-2021-054945.
  • Watt-Watson J, McGillion M, Hunter J, Choiniere M, Clark AJ, Dewar A, Johnston C, Lynch M, Morley-Forster P, Moulin D, et al. A survey of prelicensure pain curricula in health science faculties in Canadian universities. Pain Res Manag. 2009;14(6):439–44. doi:10.1155/2009/307932.
  • National Center on Addiction and Substance Abuse. Under the counter: the diversion and abuse of controlled prescription drugs in the US. New York (NY): Columbia University; 2005.
  • Raheemullah A, Andruska N, Saeed M, Kumar P. Improving residency education on chronic pain and opioid use disorder: evaluation of CDC guideline-based education. Subst Use Misuse. 2020;55(4):684–90. doi:10.1080/10826084.2019.1691600.
  • Vargovich AM, Schumann ME, Xiang J, Ginsberg AD, Palmer BA, Sperry JA. Difficult conversations: training medical students to assess, educate, and treat the patient with chronic pain. Acad Psychiatry. 2019;43(5):494–98. doi:10.1007/s40596-019-01072-4.
  • Lynch ME, Campbell F, Clark AJ, Dunbar MJ, Goldstein D, Peng P, Stinson J, Tupper H. A systematic review of the effect of waiting for treatment for chronic pain. Pain. 2008;136(1–2):97–116. doi:10.1016/j.pain.2007.06.018.
  • Choinière M, Peng P, Gilron I, Buckley N, Williamson O, Janelle-Montcalm A, Baerg K, Boulanger A, Di Renna T, Finley GA, et al. Accessing care in multidisciplinary pain treatment facilities continues to be a challenge in Canada. Reg Anesth Pain Med. 2020;45(12):943–48. doi:10.1136/rapm-2020-101935.
  • Eccleston C, Blyth FM, Dear BF, Fisher EA, Keefe FJ, Lynch ME, Palermo TM, Reid MC, Williams ACC. Managing patients with chronic pain during the COVID-19 outbreak: considerations for the rapid introduction of remotely supported (eHealth) pain management services. Pain. 2020;161(5):889–93. doi:10.1097/j.pain.0000000000001885.
  • Lynch ME, Campbell FA, Clark AJ, Dunbar MJ, Goldstein D, Peng P, Stinson J, Tupper H. Waiting for treatment for chronic pain - a survey of existing benchmarks: toward establishing evidence-based benchmarks for medically acceptable waiting times. Pain Res Manag. 2007;12(4):245–48. doi:10.1155/2007/891951.
  • Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005;3(3):209–14. doi:10.1370/afm.310.
  • Neprash HT, Barnett ML. Association of primary care clinic appointment time with opioid prescribing. JAMA netw open. 2019;2(8):e1910373. doi:10.1001/jamanetworkopen.2019.10373.
  • Puntillo F, Giglio M, Brienza N, Viswanath O, Urits I, Kaye AD, Pergolizzi J, Paladini A, Varrassi G. Impact of COVID-19 pandemic on chronic pain management: looking for the best way to deliver care. Best Pract Res Clin Anaesthesiol. 2020;34(3):529–37. doi:10.1016/j.bpa.2020.07.001.
  • Shanthanna H, Strand NH, Provenzano DA, Lobo CA, Eldabe S, Bhatia A, Wegener J, Curtis K, Cohen SP, Narouze S. Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel. Anaesthesia. 2020;75(7):935–44. doi:10.1111/anae.15076.